PTJA09 – ‘Brolucizumab for the treatment of adults with neovascular (wet) age-related macular degeneration (AMD)’ project plan now available

The final project plan  of the relative effectiveness of  ‘Brolucizumab for the treatment of adults with neovascular (wet) age-related macular degeneration (AMD)’ is now available for access. The final assessment report will be published on 12th March, 2020. Below is the documentation provided by the Joint Assessment authoring team. PTJA09 Final Project Plan

OTCA22 – Final Assessment Report and related documents now available

The final assessment report and related documents for the Other Technologies Collaborative Assessment ‘Point-of-care Tests (POCT): D-Dimer and Troponin’ are now available for access. Troponin and D-dimer point of care tests can be used to aid the diagnosis of patients with symptoms suggestive of suspected acute coronary syndrome and venous thromboembolism respectively. This report aimed […]

November 2019 Implementation Report – Now Available

EUnetHTA is pleased to announce ​the new Implementation Report with Appendices are now available for access. ​The report covers the updated use and uptake on all Joint Action 3 assessments. The report and all related documentation is available at this link, or via the National Uptake and Case Studies visuals here.

OTCA17 – Final Assessment Report and related documents now available

The final assessment report and related documents for the Other Technologies Collaborative Assessment ‘Lithium triborate (LBO) laser for photoselective vaporisation of the prostate (PVP) in the treatment of benign prostatic hyperplasia (BPH)’ are now available for access. The present assessment addressed the research question whether the lithium triborate (LBO) laser for photoselective vaporisation of the […]

OCTA20 Final Assessment Report is now available.

We are pleased to announce that the final assessment report for OTCA20 ‘Prophylactic or therapeutic use of endoanchoring systems in endovascular aortic aneurysm repair (EVAR/TEVAR)’, together with the fact check comments from manufacturers and comments from external experts including the replies of the author, are now available for access. The health technology assessed is a […]

OCTA20 Final Assessment Report is now available.

We are pleased to announce that the final assessment report for OTCA20 ‘Prophylactic or therapeutic use of endoanchoring systems in endovascular aortic aneurysm repair (EVAR/TEVAR)’, together with the fact check comments from manufacturers and comments from external experts including the replies of the author, are now available for access. The health technology assessed is a […]

OTCA18 Final Assessment Report is now available.

The final assessment report and related documents concerning OTCA18, ‘regional hyperthermia for high-risk soft tissue sarcoma treatment’, are now available. The assessed technology is regional hyperthermia added to conventional therapies to treat high-risk soft tissue sarcoma. The objective of this rapid relative effectiveness assessment was to collaboratively address the research question: Is the regional application […]